Epigenomics AG N
Epigenomics AG N (FWB: ECX) is trading at €0.96, about ₹104 at today's EUR/INR rate, as of 29 Sep 2026, 3:19 AM ET, up 0.53% today. Indian residents can buy Epigenomics AG N from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
€0.95
Today's high
€0.96
52 week low
€0.60
52 week high
€1.59
ECX opened at €0.95, closed previously at €0.95, and has traded between €0.60 and €1.59 over the past 52 weeks.
About
Epigenomics AG currently has no significant business activities. Historically, the firm concentrated its efforts on developing liquid biopsy methods for the early identification of cancer. The company was established in 1998 and is based in Heidelberg, Germany.
Key statistics
Avg. volume
455.00
Market cap
€853.02K
P/E Ratio
-0.05
Price-to-sales ratio
1.26
Enterprise value
€11.80M
Free cash flow yield
0.00%
Debt-to-equity ratio
0.08
Return on equity
-15700.00%
ROIC
-2.87%
Beta
0.87
Dividend yield
0.00%
Last dividend
€0.00
Financial overview
Revenue
€24.00K
Earnings per share
-€0.36
Free cash flow
-€5.71M
Net profit margin
-2479.18%
Gross margin
75.26%
EBITDA
-€314.00K
Revenue growth
0.00%
How to buy Epigenomics AG N from India
Indian residents can buy Epigenomics AG N shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to EUR.
Search for Epigenomics AG N and place an order
Find Epigenomics AG N by name or by its ticker, ECX, and choose an order type. Epigenomics AG N trades 11:30 am – 11:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Epigenomics AG N position in EUR and INR. Epigenomics AG N pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Epigenomics AG N from India
Trading and taxes when buying Epigenomics AG N from India
Trading and limits
- Trading hours
- 8:00 am – 8:00 pm CET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneEpigenomics AG N does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Epigenomics AG N stock?
Yes. Epigenomics AG N (ECX) has been listed on the Frankfurt Stock Exchange since 2004, in the Medical - Diagnostics & Research industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to EUR. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Epigenomics AG N share cost in rupees?
One Epigenomics AG N share is €0.96 — about ₹104 at an EUR/INR rate of 108.91 on 29 Sep 2026. Both the Epigenomics AG N price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Epigenomics AG N from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
How are gains on Epigenomics AG N shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the EUR/INR rate on the purchase and the sale date, so the rupee move counts alongside the Epigenomics AG N price. Paasa issues a capital-gains statement for your return.
Does Epigenomics AG N pay a dividend?
No. Epigenomics AG N does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Epigenomics AG N from India?
The Frankfurt Stock Exchange trades 11:30 am – 11:30 pm IST in Indian time. The window shifts to 12:30 pm – 12:30 am IST when Germany is on standard time. Orders can only execute during that window.
Do I have to declare Epigenomics AG N shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Epigenomics AG N holding, its cost and its closing value.
How do I sell Epigenomics AG N and bring the money back to India?
You sell during market hours (11:30 am – 11:30 pm IST) and the proceeds settle in EUR in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.
Does the rupee rate affect what I make on Epigenomics AG N?
Yes. Epigenomics AG N is priced in EUR, so your rupee outcome combines the EUR move with the EUR/INR move between the day you remit and the day you convert back. Both directions are reflected in the capital-gains statement Paasa issues.